[Rhabdomyosarcoma of the prostate. Diagnostic course and current therapy. Report of a case of a 17-year-old boy].
The authors report a case of rhabdomyosarcoma in a 17 year old boy which recurred after combination chemotherapy and radical prostatectomy, followed by death of the patient due to haematological complications of second-line chemotherapy. The diagnosis of these rhabdomyosarcomas is facilitated by the various immunohistochemical stains now available. Chemotherapy is undeniably effective and, combined with surgery and radiotherapy, ensures a 5-year survival of 47% to 93% depending on the stage. The first-line chemotherapy avoids the need for radiotherapy in the early stages and allows less mutilating surgical procedures, while maintaining the survival rate.
Saussine
C
C
Service de Chirurgie Urologique, C.H.U. Strasbourg.
Jacqmin
D
D
Babin-Boilletot
A
A
Ghnassia
J P
JP
Bollack
C
C
D000293:Adolescent; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000628:therapy; D012208:Rhabdomyosarcoma / Q000175:diagnosis / Q000628:therapy
Le rhabdomyosarcome de la prostate. Evolution diagnostique et thérapeutique actuelle. A propos d'un cas chez un garçon de 17 ans.